Free Trial
NASDAQ:TTRX

Turn Therapeutics 11/13/2025 Earnings Results & Report

Turn Therapeutics logo
$8.59 -0.76 (-8.14%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Turn Therapeutics reported earnings on November 13, 2025. The company reported EPS of -$0.07.

Earnings Announcement Details

Time
Before Market Opens

Turn Therapeutics EPS Results

Actual EPS
-$0.07
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Turn Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Turn Therapeutics Earnings FAQ

Turn Therapeutics (NASDAQ:TTRX) reported earnings of -$0.07 per share for the quarter. The report was announced on Thursday, November 13, 2025.

Turn Therapeutics Earnings Headlines

Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
Turn Therapeutics Inc. GAAP EPS of -$0.21
See More Turn Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Turn Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Turn Therapeutics and other key companies, straight to your email.

About Turn Therapeutics

Turn Therapeutics (NASDAQ:TTRX) is a biotechnology company focused on developing topical products for skin health, wound care and infection management. Its work centers on formulations intended to deliver antimicrobial treatment directly to affected areas.

The company has developed products for wound care and other topical applications, using its formulation technology to address needs in dermatology and related fields. Turn Therapeutics is based in the United States and has focused on developing and commercializing its products in the U.S. market.

View Turn Therapeutics Profile